[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338311-105":59,"doc-detail-338311-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","characterization-of-stem-cell-landscape-and-assessing-the-stemness-degree-to-aid-clinical-therapeutics-in-hematologic-malignancies","Characterization of stem cell landscape and assessing the stemness degree to aid clinical therapeutics in hematologic malignancies","","Hematological malignancies are driven in part by cancer stem cells (CSCs), which can initiate disease, promote progression, and contribute to relapse; however, identifying and targeting CSCs remains difficult. The study develops a stemness index (HSCsi) and a novel one-class logistic regression (OCLR) approach to find transcriptomic feature sets linked to stemness. Using HSCsi, the stemness of leukemia stem cells is quantified, correlated with drug resistance and immune microenvironment signals in acute myeloid leukemia, and associated with survival and relapse. The index also supports candidate drug and intervention discovery to improve clinical stratification and therapy selection.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/characterization-of-stem-cell-landscape-and-assessing-the-stemness-degree-to-aid-clinical-therapeutics-in-hematologic-malignancies/338311/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/characterization-of-stem-cell-landscape-and-assessing-the-stemness-degree-to-aid-clinical-therapeutics-in-hematologic-malignancies/338311.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"How does the index help propose therapeutic strategies?","Question",{"text":112,"@type":113},"By linking stemness to biological mechanisms and immune microenvironment context, HSCsi identifies potential drugs and interventions aimed at cancer stem cells and supports precise patient stratification for targeted and immunotherapies.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},338311,1790929888,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":19,"preview_urls":138},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCharacterization of stem cell landscape and assessing the stemness degree to aid clinical therapeutics in hematologic malignancies  \nYuan-dong Feng1,3, Jin Du2,3, Hong-li Chen1, Ying Shen1, Ya-chun Jia1, Peng-yu Zhang1, Aili He1 & Yun Yang1􀀍  \nHematological malignancies are a group of cancers that affect the blood, bone marrow, and lymphatic system. Cancer stem cells (CSCs) are believed to be responsible for the initiation, progression, and relapse of hematological malignancies. However, identifying and targeting CSCs presents many challenges. We aimed to develop a stemness index (HSCsi) to identify and guide the therapy targeting CSCs in hematological malignancies. We developed a novel one-class logistic regression (OCLR) algorithm to identify transcriptomic feature sets related to stemness in hematologic malignancies. We used the HSCsi to measure the stemness degree of leukemia stem cells (LSCs) and correlate it with clinical outcomes.We analyze the correlation of HSCsi with genes and pathways involved in drug resistance and immune microenvironment of acute myeloid leukemia (AML) . HSCsi revealed stemnessrelated biological mechanisms in hematologic malignancies and effectively identify LSCs. The index also predicted survival and relapse rates of various hematologic malignancies. We also identified potential drugs and interventions targeting cancer stem cells (CSCs) of hematologic malignancies by the index. Moreover, we found a correlation between stemness and bone marrow immune microenvironment inAML. Our study provides a novel method and tool to assess the stemness degree of hematologic malignancies and its implications for clinical outcomes and therapeutic strategies. Our HSC stemness index can facilitate the precise stratification of hematologic malignancies, suggest possible targeted and immunotherapy options, and guide the selection of patients.  \nKeywords hematologic malignancy, Machine learning, Leukemia stem cell, Drug sensitivity, Bone marrow microenvironment  \nAbbreviations  \nALCL ALLAMLATILATLLAUCCLLCML CSC DEG DLBCLENKT  \nAnaplastic large cell lymphoma Acute lymphoblastic leukemia Acute myelocytic leukemia Angioimmunoblastic T-cell lymphoma Adult T-cell leukemia/lymphoma Area under the curve  \nChronic lymphocytic leukemia Chronic myelocytic leukemia Cancer stem cell  \nDifferentially expressed gene Diffuse large B-Cell lymphoma Extranodal NK/T-cell lymphoma  \n1Department of Hematology, The Second Affiliated Hospital of Xi’an Jiaotong University, 157 West 5Th Road, Xi’an 710004, China. 2Department of Stomatology, The Third Affiliated Hospital of Xi’an Medical University, 277 West Youyi Road, Xi’an 710068, China. 3Yuan-dong Feng and Jin Du: These authors contributed equally to this study.  \n􀀍 [email: yangyun108@mail.xjtu.edu.cn](email: yangyun108@mail.xjtu.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nESC ESTIMATE ET  \nGDSC  \nGO  \nHPC  \nHSC  \nIC50  \nLSC LT-HSCMDS  \nMMMSigDB OCLR  \nPBMC PI3K/mTOR PMF  \nPTCL  \nPV  \nROC  \nRTKssGSEAST-HSCSVM-RFE TIDE WGCNA  \nEmbryonic stem cell  \nEstimation of Stromal and Immune cells in Malignant Tumors using Expression data Essential thrombocythaemia  \nGenomics of Drug Sensitivity in Cancer Gene Ontology  \nHematopoietic progenitor cell Hematopoietic stem cell  \nHalf maximal inhibitory concentration Leukemia stem cell  \nLong-term hematopoietic stem cell Myelodysplastic syndromes Multiple myeloma  \nMolecular Signature Database One-class logistic regression Peripheral blood mononuclear cell  \nPhosphatidylinositol-3-kinase/mechanistic target of rapamycin Primary myelofibrosis  \nPeripheral T Cell Lymphoma Polycythemia vera  \nReceiver operating characteristic Receptor tyrosine kinase  \nSingle sample gene set enrichment analysis Short-term hematopoietic stem cell  \nSupport Vector Machine-Recursive Feature Elimination Tumor Immune Dysfunction and Exclusion Weighted correlatio","cbCaitLnDBC0ZyHk","https://ap.wps.com/l/cbCaitLnDBC0ZyHk","pdf",17143813,21,"English","# Introduction\n## Rationale for targeting cancer stem cells\n## Limitations in identifying CSCs\n# Methods and index development\n## One-class logistic regression for transcriptomic features\n## Stemness index (HSCsi) definition and computation\n# Results and clinical relevance\n## Correlation with genes and pathways in AML\n## Prediction of survival and relapse\n## Links to bone marrow immune microenvironment\n## Candidate drugs and interventions","[{\"question\":\"How does the index help propose therapeutic strategies?\",\"answer\":\"By linking stemness to biological mechanisms and immune microenvironment context, HSCsi identifies potential drugs and interventions aimed at cancer stem cells and supports precise patient stratification for targeted and immunotherapies.\"}]","Characterization of stem cell landscape and assessing the stemness degree to aid clinical therapeutics in hematologic malignancies | PDF",1790022996,53,[139,143,147,151],{"page_no":8,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4284fcbbc6ee7f599f039d65b923388.webp",983,1291,{"page_no":14,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be1e37909e94a8578d461ffd87d939ef.webp",982,1290,{"page_no":81,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a39afd5f8f57818527bb14fdce55ef4b.webp",981,1289,{"page_no":19,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84fda544d852a41e0c3d4a1f1d5ccc79.webp",980,1287]